Abstract
Paraffin embedded tissue of 49 stage C and 27 stage B prostate adenocarcinomas was investigated by flow cytometry. All patients were treated by radical prostatectomy with pelvic lymphadenectomy and followed up for 5–10 years. The tumour was separated from the benign tissue to increase the proportion of tumour cells. Ten stage C and seven stage B carcinomas had to be excluded because of poor fixation. Six of the 39 (15%) stage C and 1/20 (5%) stage B carcinomas were aneuploid. Cell cycle analysis was done with correction for sliced nuclei and background subtraction. The threshold between carcinomas with low and with increased (“tetraploid”) G2M-fraction was determined by comparing carcinomas with and without tumour progression. Sixty-seven percent of the patients with non-euploid stage C carcinomas and 11% of those with euploid carcinomas suffered from tumour progression (P<0.01). The respective values for the stage B carcinomas were 67% and 6% (P<0.01). These results demonstrate the strong prognostic impact of DNA-ploidy and G2M-fractions for each individual patient.
Similar content being viewed by others
References
Alanen KA, Joensuu H, Klemi PJ (1989) Autolysis is a potential cause of false aneuploid peaks in flow cytometry DNA histograms. Cytometry 10:417–425
Böcking A, Chatelain R, Orthen U, Gien G, Kalckreuth G von, Jocham D, Wohltmann D (1988) DNA-grading of prostatic carcinoma: prognostic validity and reproducibility. Anticancer Res 8:129–135
Brothman AR, Lesho LJ, Somers KD, Schellhammer PF, Ladage LE, Merchant DJ (1989) Cytogenetic analysis of four primary prostatic cultures. Cancer Genet Cytogenet 37:241–248
Camplejohn RS, Macartney JC (1986) Comments of “effects of section thickness on quality of flow cytometric DNA content determinantion in paraffin-embedded tissues”. Cytometry 7:612–615
Dean PN (1985) Methods of data analysis in flow cytometry. In: Dilla MA van, Dean PN, Laerum OD, Melamed MR (eds) Flow cytometry: instrumentation and data analysis. Academic Press, pp 195–221
Deitch AD, Stand MA, White RW deVere (1989) Deoxyribonucleic acid flow cytometry of benign prostatic disease. J Urol 142:759–762
Dejter SW, Cunningham RE, Noguchi PD, Jones RV, Moul JW, McLeaod DG, Lynch JH (1989) Prognostic significance of DNA ploidy in carcinoma of prostate. Urology 33:361–366
Feichter GE, Goerttler K (1986) Pitfalls in the preparation of nuclear suspensions from paraffin-embedded tissue for flow cytometry. Cytometry 7:616–619
Fordham MVP, Burdge AH, Matthews J, Williams G, Cooke T (1986) Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome. Br J Surg 73:400–403
Forsslund G, Zetterberg A (1990) Ploidy level determinations in high-grade and low-grade malignant variants of prostatic carcinoma. Cancer Res 50:4281–4285
Frankfurt OS, Chin JL, Englander LS, Greco WR, Pontes JE, Rustum YM (1985) Relationship between DNA ploidy, glandular differentiation and tumor spread in human prostate cancer. Cancer Res 45:1418–1423
Frohmüller H, Theiβ M, Wirth MP (1991) Radical prostatectomy for carcinoma of the prostate — long term follow up of 115 patients. Eur J Urol 19:279–283
Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333–1335
Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman CJ, Reif RC, Mayall BH, Murphy RF, Sandberg AA (1984) Convention on nomenclature for DNA cytometry. Cytometry 5:445–446
Joensuu H, Kallioniemi O-P (1989) Different opinions on classification of DNA histograms produced from paraffin-embedded tissue. Cytometry 10:711–717
Kallioniemi OP, Visakorpi T, Holli K, Heikkinen A, Isola J, Koivula T (1991) Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry 12:413–421
Klein FA, Ratliff JE, White FK (1988) DNA distribution patterns of prostatic tissue obtained at time of transurethral resection. Urology 31:260–265
Lee SE, Currin SM, Paulson DF, Walther PJ (1988) Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence. J Urol 140:769–774
Limon J, Lundgren R, Elfving P, Heim S, Kristoffersson U, Mandahl N, Mitelman F (1989) Double minutes in two primary adenocarcinomas of the prostate. Cancer Genet Cytogenet 39:191–194
Lundberg S, Carstensen J, Rundquist I (1987) DNA flow cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study. Cancer Res 47:1973–1977
Malinin TI, Hornicek FJ, Block NL, Malinin GI (1988) Aneuploidy of glandular epithelial cells in histological normal prostate glands. Experientia 44:247–249
McIntire TL, Murphy WM, Coon JS, Chandler RW, Schartz D, Conway S, Weinstein RS (1988) The prognostic value of DNA ploidy combined with histologic substaging for incidental carcinoma of the prostate gland. Am J Clin Pathol 89:370–373
Miller J, Horsfall DJ, Marshall VR, Rao DM, Leong SY (1991) The prognostic value of deoxyribonucleic acid flow cytometric analysis in stage D2 prostatic carcinoma. J Urol 145:1192–6
Montgomery BT, Nativ O, Blute ML, Farrow GM, Myers RP, Zincke H, Therneau TM, Lieber MM (1990) Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis. Arch Surg 125:327–331
Müller H-A, Altenähr E, Böcking A, Dhom G, Faul P, Göttinger H, Helpap B, Hohbach Ch, Kastendieck H, Leistenschneider W (1980) Über Klassifikation und Grading des Prostatakarzinoms. Verh Dtsch Ges Pathol 64:609–611
Nativ O, Winkler HZ, Raz Y, Therneau TM, Farrow GM, Myers RP, Zincke H, Lieber MM (1989) Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. Mayo Clin Proc 64:911–919
Neill WA, Norval M, Habib FK (1989) Nuclear DNA analysis of prostate tissues: correlation with stage and grade of tumour. Urol Int 44:141–146
Schellhammer PF (1988) Radical prostatectomy. Patterns of local failure and survival in 67 patients. Urology 31:191–197
Schultz RE, Varello MA, Tsou KC, Wein AJ, Murphy JJ (1985) Simultaneous flow cytometric deoxyribonucleic acid and acid phosphatase analysis of benign and malignant lesions of the prostate. J Urol 134:1133–1136
Seppelt U, Sprenger E (1984) Nuclear DNA cytophotometry in prostate carcinoma. Cytometry 5:258–262
Shackney SE, Burholt DR, Pollice AA, Smith CA, Pugh RP, Hartsock RJ (1990) Discrepancies between flow cytometric and cytogenetic studies in the detection of aneuploidy in human solid tumors. Cytometry 11:94–104
Stephenson RA, Gay H, Fair WR, Melamed MR (1986) Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embedded tissues. Cytometry 7:41–43
Stephenson RA, James BC, Gay H, Fair WR, Whitemore WF, Melamed MR (1987) Flow cytometry of prostate cancer: relationship of DNA content to survival. Cancer Res 47:2504–2507
Tavares AS, Costa J, De Carvalho A, Reis M (1966) Tumour ploidy and prognosis in carcinomas of the bladder and prostate. Br J Cancer 20:438–441
Tribukait B, Ronstrom L, Espositi P (1983) Quantitative and qualitative aspects of flow DNA measurements related to the cytologic grade in prostatic carcinoma. Anal Quant Cytol Histol 5:107–111
Winkler HZ, Rainwater LM, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM (1988) Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. Mayo Clin Proc 63:103–112
Wirth MP, Müller HA, Manseck A, Müller J, Frohmüller HGW (1991) Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy. Eur Urol 20:248–252
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller, J.G., Demel, S., Müller, H.A. et al. DNA-ploidy, G2M-fractions and prognosis of stages B and C prostate carcinoma. Vichows Archiv A Pathol Anat 424, 647–651 (1994). https://doi.org/10.1007/BF00195780
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00195780